Label: LOPERAMIDE HYDROCHLORIDE tablet

  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated September 27, 2012

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • ACTIVE INGREDIENT (IN EACH CAPLET)

    Loperamide HCI USP, 2 mg

  • PURPOSE

    Anti-diarrheal

  • USES

    Controls symptoms of diarrhea, including Travelers’ Diarrhea

  • WARNINGS

    Allergy alert: Do not use if you have ever had a rash or other allergic reaction to loperamide HCI

    Do not use

    If you have bloody or black stool

    Ask a doctor before use if you have

    • fever
    • mucus in the stool
    • a history of liver disease

    Ask a doctor or pharmacist before use if you are

    Taking antibiotics

    When using this product

    • tiredness, drowsiness or dizziness may occur. Be careful when driving or operating machinery.

    Stop use and ask a doctor if

    • diarrhea lasts for more than 2 days
    • symptoms get worse
    • you get abdominal swelling or bulging. These may be signs of a serious condition.

    If pregnant or breast-feeding

    Ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • DIRECTIONS

    • drink plenty of clear fluids to help prevent dehydration caused by diarrhea
    • find right dose on chart. If possible, use weight to dose; otherwise, use age.
      adults and children 12 years and over2 caplets after the first loose stool;
      1 caplet after each subsequent loose stool; but no more than 4 caplets in 24 hours
      children 9-11 years
      (60-95 lbs)      		1 caplet after the first loose stool;
      ½ caplet after each subsequent loose stool; but no more than 3 caplets in 24 hours
      children 6-8 years
      (48-59 lbs)      		1 caplet after the first loose stool;
      ½ caplet after each subsequent loose stool; but no more than 2 caplets in 24 hours
      children under 6 years
      (up to 47 lbs)      		ask a doctor
  • OTHER INFORMATION

    • store between 20° – 25° C (68° – 77° F)
    • see side panel for lot number and expiration date
    • TAMPER EVIDENT: THIS PRODUCT PROTECTED WITH SEALED BLISTER UNITS. DO NOT USE IF ANY ARE TORN OR BROKEN.
  • INACTIVE INGREDIENTS

    Anhydrous lactose, croscarmellose sodium, crospovidone, D&C yellow no.10, FD&C blue no.1, hydrogenated vegetable oil, magnesium stearate, powdered cellulose, pregelatinized starch

  • QUESTIONS?

    Call 1800-406-7984

  • PRINCIPAL DISPLAY PANEL

    select brand®

    NDC 15127-338-12

    Loperamide Hydrochloride Tablets USP, 2 mg

    ANTI-DIARRHEAL

    Controls The Symptoms Of Diarrhea

    ٭Compare to the active ingredient of Imodium®A-D

    12 Caplets*

    Each Caplet (*capsule-shaped tablet) contains Loperamide HCl USP, 2 mg

    5048836/R1109

    This is the 12 count blister carton label for Select Brand Loperamide HCl tablets USP, 2 mg.
  • INGREDIENTS AND APPEARANCE
    LOPERAMIDE HYDROCHLORIDE 
    loperamide hydrochloride tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:15127-338
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LOPERAMIDE HYDROCHLORIDE (UNII: 77TI35393C) (LOPERAMIDE - UNII:6X9OC3H4II) LOPERAMIDE HYDROCHLORIDE2 mg
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    CROSPOVIDONE (UNII: 68401960MK)  
    D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    TRISTEARIN (UNII: P6OCJ2551R)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    POWDERED CELLULOSE (UNII: SMD1X3XO9M)  
    STARCH, PREGELATINIZED CORN (UNII: O8232NY3SJ)  
    Product Characteristics
    ColorgreenScore2 pieces
    ShapeCAPSULESize9mm
    FlavorImprint Code 123
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:15127-338-666 in 1 BLISTER PACK
    2NDC:15127-338-1212 in 1 BLISTER PACK
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07409102/01/1993
    Labeler - Select Brand (043562370)
    Registrant - Ranbaxy Pharmaceuticals Inc. (937890044)
    Establishment
    NameAddressID/FEIBusiness Operations
    Ohm Laboratories Inc.051565745manufacture(15127-338)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!